HANOI, U.S. Embassy & Consulates in Vietnam --
The U.S. Mission to Vietnam is proud to announce COVAX delivered an additional 2,633,670 life-saving doses of the Pfizer-BioNTech vaccine made available by the United States to assist Vietnam in its fight against COVID-19. 1,317,420 doses arrived on October 24 in Hanoi, and 1,316,250 doses arrived on October 25 in Ho Chi Minh City. This is the sixth COVAX delivery to Vietnam, totaling 12.1 million COVID-19 vaccine doses made available by the United States so far.
The United States has supported Vietnam since the beginning of the pandemic and has committed more than $30.2 million in COVID-19 related assistance for Vietnam. Continuing to build on our longstanding cooperation and investment in Vietnam’s health infrastructure, we have provided support to essentially every pillar of the country’s pandemic response. From virtual trainings that have reached thousands of hospital workers in the Mekong provinces with skills to protect themselves from infection, to genetic sequencing technology that allows Vietnam to track variants of the virus that are circulating, to information systems that guide rapid vaccine delivery to provinces to reach those at highest risk; from supplying COVID-19 test and vaccine storage equipment to bolstering Vietnam’s COVID-19 care systems, especially in Ho Chi Minh City and neighboring hard-hit provinces, by providing life-saving equipment such as ventilators, oxygen concentrators, and liquid-oxygen tanks for patience in need. We stand shoulder-to-shoulder with Vietnam in the fight against COVID-19.
At the Global COVID-19 Summit on September 22, the President announced a commitment to provide an additional 500 million Pfizer doses to 92 low- and middle-income countries around the world, and the African Union, bringing the U.S. total global commitment to more than 1.1 billion doses. Vietnam has been a leading recipient of these doses.
Worldwide, the United States has delivered more than 200 million doses of COVID-19 vaccines to more than 100 countries. We will continue to donate additional vaccine doses globally as supply becomes available. We are also working with U.S. vaccine manufacturers to increase vaccine supply for the rest of the world and with partners to expand global vaccine production and manufacturing capacity to beat this pandemic.